Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Tiberi

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Clinical Medicine (London, England)|June 3, 2015
Inverse psoriasisAnna Zampetti, Simon Tiberi
The Lancet. Infectious Diseases|December 24, 2019
What is the best regimen to treat latent tuberculosis infection?Simon Tiberi, Giovanni Battista Migliori
Internal and Emergency Medicine|October 18, 2012
Tuberculosis a re-emerging diseaseSaverio De Lorenzo, Simon Tiberi
Infectious Disease Clinics of North America|November 1, 2019
Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and TreatmentSimon Tiberi, Alimuddin Zumla, Giovanni Battista Migliori
Current Opinion in Pulmonary Medicine|February 9, 2021
Atypical mycobacterial infections - management and when to treatLaura Indira Gill, Catherine Dominic, Simon Tiberi
The Lancet. Respiratory Medicine|March 30, 2018
Defining the best regimen to treat isoniazid-resistant tuberculosisGiovanni Battista Migliori, Simon Tiberi, Giovanni Sotgiu
Respiratory Medicine Case Reports|June 2, 2022
Case studies to illustrate good practice in the management of non-tuberculous mycobacterial pulmonary diseaseSimon Tiberi, Marc C Lipman, Andres Floto
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 16, 2017
Post-implementation blues: the unfulfilled potential of XpertSimon Tiberi, Emanuele Pontali, Giovanni Battista Migliori
The Lancet. Infectious Diseases|February 18, 2018
Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosisMarina Tadolini, Simon Tiberi, Giovanni Battista Migliori
Nature Reviews. Drug Discovery|March 24, 2018
Accelerating the development of therapeutic strategies for drug-resistant tuberculosisMichael J Vjecha, Simon Tiberi, Alimuddin Zumla
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Clinical Medicine (London, England)|June 3, 2015
Inverse psoriasisAnna Zampetti, Simon Tiberi
The Lancet. Infectious Diseases|December 24, 2019
What is the best regimen to treat latent tuberculosis infection?Simon Tiberi, Giovanni Battista Migliori
Internal and Emergency Medicine|October 18, 2012
Tuberculosis a re-emerging diseaseSaverio De Lorenzo, Simon Tiberi
Infectious Disease Clinics of North America|November 1, 2019
Multidrug and Extensively Drug-resistant Tuberculosis: Epidemiology, Clinical Features, Management and TreatmentSimon Tiberi, Alimuddin Zumla, Giovanni Battista Migliori
Current Opinion in Pulmonary Medicine|February 9, 2021
Atypical mycobacterial infections - management and when to treatLaura Indira Gill, Catherine Dominic, Simon Tiberi
The Lancet. Respiratory Medicine|March 30, 2018
Defining the best regimen to treat isoniazid-resistant tuberculosisGiovanni Battista Migliori, Simon Tiberi, Giovanni Sotgiu
Respiratory Medicine Case Reports|June 2, 2022
Case studies to illustrate good practice in the management of non-tuberculous mycobacterial pulmonary diseaseSimon Tiberi, Marc C Lipman, Andres Floto
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 16, 2017
Post-implementation blues: the unfulfilled potential of XpertSimon Tiberi, Emanuele Pontali, Giovanni Battista Migliori
The Lancet. Infectious Diseases|February 18, 2018
Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosisMarina Tadolini, Simon Tiberi, Giovanni Battista Migliori
Nature Reviews. Drug Discovery|March 24, 2018
Accelerating the development of therapeutic strategies for drug-resistant tuberculosisMichael J Vjecha, Simon Tiberi, Alimuddin Zumla
Pageof 15